Report cover image

Global Anti-thrombin III Testing Market Growth (Status and Outlook) 2025-2031

Published Sep 05, 2025
Length 80 Pages
SKU # LPI20370038

Description

According to this study, the global Anti-thrombin III Testing market size will reach US$ million by 2031.

Antithrombin (AT, Antithrombin III, ATIII) is a small glycoprotein produced by the liver that inactivates several enzymes of the coagulation system.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

LPI (LP Information)' newest research report, the “Anti-thrombin III Testing Industry Forecast” looks at past sales and reviews total world Anti-thrombin III Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Anti-thrombin III Testing sales for 2025 through 2031. With Anti-thrombin III Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-thrombin III Testing industry.

This Insight Report provides a comprehensive analysis of the global Anti-thrombin III Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anti-thrombin III Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-thrombin III Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-thrombin III Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-thrombin III Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-thrombin III Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Diagnosis of antithrombin deficiency
Activity assays
Immunological assays

Segmentation by Application:
Hospital
Research institute
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Danaher Corp.
F. Hoffmann-La Roche Ltd.
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc.

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

80 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Anti-thrombin III Testing Market Size by Player
4 Anti-thrombin III Testing by Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Global Anti-thrombin III Testing Market Forecast
11 Key Players Analysis
12 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.